Table of Contents
MCGResearch and Jinfiniti Biosciences LLC
MCGResearch is the newest innovation in medical science that is helping doctors to better treat patients. It has shown promise in the treatment of various diseases, including cancer, cardiovascular disease, and neurodegenerative diseases. Here’s a look at a few of the research projects underway.
Cancer
Using cancer-based criteria, the MCG Programme aimed to make BRCA genetic testing routine for appropriate cancer patients. It incorporated a structured literature review, real-world evidence and international guidelines.
The criteria were approved by the National Institute for Health Research (NIHR), the Royal Marsden and the Institute of Cancer Research. The MCG Programme was also supported by the National Comprehensive Cancer Network (NCCN).
The goals of the MCG programme were to understand fundamental cellular processes and dysregulated molecular signaling pathways. It also focused on cancer prevention.
The MCG programme had two subprojects. The first was a quality improvement program. The second was a breast cancer study. This study used international guidelines and real-world evidence to estimate a 10% mutation detection rate. The criteria were also tested for 5 rare higher penetrance predisposition genes.
Cardiovascular disease
Among the leading causes of death, cardiovascular disease is a complex condition that involves the cardiovascular system. Its development and progression is regulated by the endothelium, which controls inflammation and immune cell trafficking. Cardiovascular disease research is essential to understanding the underlying causes and developing effective treatments.
Cardiovascular disease research involves a wide variety of studies. For example, population studies can help identify risk factors, and clinical trials can investigate new treatments. There is also research on pathogenesis, which provides physiological and pathological information.
The British Heart Foundation is the UK’s leading independent funder of cardiovascular research. The foundation also hosts the BHF Clinical Research Collaborative, which brings together researchers to advance the scientific agenda on cardiovascular diseases. Research is also conducted at the Bristol Biomedical Research Centre, which develops interventions for cardiac surgery patients.
Nuclear medicine
Several technological breakthroughs in nuclear medicine research have been achieved over the past half century. These advances have contributed to the field’s role in biomedical research and disease management. However, nuclear medicine has faced a number of hurdles and has yet to reach its full potential.
The most notable advancements in nuclear medicine are those that involve the use of radiopharmaceuticals. These are substances that are attached to target tissue receptor sites and accumulate in the body. This allows for the measurement of the activity of certain molecules and their interaction with other molecules.
In addition, nuclear medicine imaging has become a more important component of medical care. This involves the use of radioactive tracers that can be tracked through the body with special cameras. This allows for the detection of molecular targets at nanomolar concentrations. This technology is also used to assess numerous physiological functions, including bone metabolism and neurotransmitter activity.
Geotechnical engineering
Founded in 2008 by Dr. Armin Studlein, MCG research geotechnical engineering offers the latest techniques to provide insight into soil-water interaction and settlement damage. MCG’s expertise in geotechnical consulting includes structural engineering, forensics, site characterization and geotechnical laboratory tests. MCG has offices located in several states. They perform geotechnical engineering services such as slope stability analysis, underground storage tank investigations and foundation design. They also provide inspector training. Their in-house testing laboratory performs basic geotechnical laboratory tests in accordance with ASTM standards.
MCG’s staff is experienced in conducting large-scale soils testing with gravel. Their lab is capable of determining permeability, hydraulic conductivity, Young Modulus, representative Poison’s ratio and constrained modulus. They can also evaluate stockpile stability and angle of repose.
Other research areas include soil-foundation-structure interaction, earthquake engineering, coastal engineering, unsaturated soil mechanics, and materials handling. The staff also develops computer applications to solve complex civil engineering problems.
Jinfiniti Biosciences LLC
Founded by Dr. Jin-Xiong She, Jinfiniti Biosciences LLC is a biomedical research firm that is headquartered in the Life Sciences Business Development Center at the Medical College of Georgia. Its main focus is on high-throughput platforms. These platforms isolate samples in a cost-effective manner and at high speed.
The company specializes in providing high-end services to the biomedical research industry, including rapid screening and toxicity evaluation. In addition, it provides innovative biomarkers that can improve patients’ lives. As part of its mission to improve human health, the company is working on several novel drugs and companion biomarkers for personalized medicine. In addition to developing new drugs, the company is conducting the first and the largest randomised control trial in the world to study the effects of a new class of drug that targets cancer-causing genes.
0